comprehensive -WSS

comprehensive

author：focus 2025-08-12 08:29:50 - browse：45

Launching your first clinical trial is the type of announcement most biotech executives eagerly anticipate, hoping to celebrate with employees. But for Celsius Therapeutics CEO Tariq Kassum, it’s proving to be more difficult than he anticipated.

That’s because in recent days, Celsius, based in Cambridge, Mass., has been forced to conduct a round of layoffs, sources told STAT. Kassum confirmed around 75% of Celsius’ 40-person team had been laid off, and disclosed that the biotech has also been quietly paring back its pipeline this year. It shut down almost all early-stage research projects, including pausing all of its cancer drug work, in order to conserve enough cash for the Phase 1 trial it announced this week.

“It’s an incredibly bittersweet moment.… The cognitive dissonance there is just really, really hard,” Kassum told STAT. “But I do think that you’re seeing a lot of other companies doing what we are, which is, as painful as it is, to focus on the nearest term value drivers, the things that can get to patients the quickest, and make the painful decisions that allow you to live to fight another day.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Walmart eyes Medicare Advantage provider ChenMed

hotspot

WSS

Aspartame and sugar

Bird flu researchers hone in on Finland’s mink farms

Senators push IRS to launch nonprofit hospital probe

How to make the FDA’s new prescription one

Long Covid needs a new name — and a new frame

How to make the FDA’s new prescription one

focus

comprehensive

focus

Activists slam private health insurers over coverage restrictions

White House touts steps to stem shortages of cancer treatments

Medical leaders decry Supreme Court decision on affirmative action

Yogurt drink instead of a colonoscopy? CRISPR bacteria are tested

Anesthesiologist group: stop taking Ozempic before surgery

How to make the FDA’s new prescription one

Walensky prepares to leave CDC — and Congress — behind

WATCH: Why do bright lights make us see spots?

Wildfire smoke exposes gaps in outdoor worker protections

Yogurt drink instead of a colonoscopy? CRISPR bacteria are tested

hotspot

Megan Rapinoe shares emotional post following US Women's World Cup exit

Will the IRA bring competition to the biologics market?

Will the IRA bring competition to the biologics market?

Generate Biomedicines machine learning biotech raises $273M

Dozens dead from Maui wildfires: What we know about the victims

Indictment alleges Trump's ex

Wikipedia

hotspot

leisure time

explore